{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T13:47:26Z","timestamp":1792849646362,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"am","delay-in-days":298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jpba.2021.114433","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T10:42:58Z","timestamp":1634640178000},"page":"114433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4174-5362","authenticated-orcid":false,"given":"Pascal","family":"Kintz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2021.114433_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1517\/17460441.2013.741582","article-title":"Deciphering the selective androgen receptor modulators paradigm","volume":"8","author":"Zhang","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jpba.2021.114433_bib2","first-page":"232","article-title":"Selective androgen receptor modulators (SARMs) as function promoting therapies","volume":"12","author":"Bhasin","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.jpba.2021.114433_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1248\/bpb.b12-00885","article-title":"Mechanism of the tissue-specific action of the selective androgen receptor modulator S-101479","volume":"36","author":"Furuya","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpba.2021.114433_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/mi.5.3.7","article-title":"Discovery and therapeutic promise of selective androgen receptor modulators","volume":"5","author":"Chen","year":"2005","journal-title":"Mol. Interv."},{"key":"10.1016\/j.jpba.2021.114433_bib5","unstructured":"\u27e8https:\/\/www.wada-ama.org\/en\/content\/what-is-prohibited\/prohibited-at-all-times\/anabolic-agents\u27e9, site consult\u00e9 le 24 mai 2021."},{"key":"10.1016\/j.jpba.2021.114433_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.forsciint.2011.07.014","article-title":"SARM-4 and metabolites detection in sports drug testing: a case report","volume":"213","author":"Grata","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2021.114433_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/dta.1768","article-title":"Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes","volume":"7","author":"Hansson","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2021.114433_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.chroma.2019.04.050","article-title":"Development and validation of a semi-quantitative ultra-high performance liquid chromatography-tandem mass spectrometry method for screening of selective androgen receptor modulators in urine","volume":"1660","author":"Ventura","year":"2019","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2021.114433_bib9","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/dta.2793","article-title":"Memorable findings: suspected and purported cases of performance manipulation","volume":"12","author":"Trevorrow","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2021.114433_bib10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/dta.2761","article-title":"Tainted toothpaste \u2013 analytical investigation into an unusual adverse finding","volume":"12","author":"Sch\u00e4nzer","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2021.114433_bib11","first-page":"e3","article-title":"What are the prerequisites to account for \u201cno fault\u201d in doping control after an adverse analytical finding possibly due to drug contamination? Perspective from a hair testing analyst","volume":"42","author":"Kintz","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2021.114433_bib12","unstructured":"\u27e8https:\/\/www.wada-ama.org\/en\/resources\/legal\/cas-wada-itf-v-gasquet\u27e9, acessed 28 June 2021."},{"key":"10.1016\/j.jpba.2021.114433_bib13","unstructured":"\u27e8https:\/\/www.canoeicf.com\/news\/icf-decision-laurence-vincent-lapointe\u27e9, acessed 28 June 2021."},{"key":"10.1016\/j.jpba.2021.114433_bib14","unstructured":"\u27e8https:\/\/www.usada.org\/sanction\/madilyn-nickles-found-at-no-fault\/\u27e9, acessed 28 June 2021."},{"key":"10.1016\/j.jpba.2021.114433_bib15","unstructured":"\u27e8https:\/\/www.doping.nl\/media\/kb\/6463\/CAS%202019_A_6313%20Jarrion%20Lawson%20vs%20IAAF%20%28OS%29.pdf\u27e9, acessed 28 June 2021."},{"key":"10.1016\/j.jpba.2021.114433_bib16","unstructured":"\u27e8https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/stakeholder_notice_meat_contamination_final_1_june_2021.pdf\u27e9, accessed 28 June 2021."},{"key":"10.1016\/j.jpba.2021.114433_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.110771","article-title":"Analysis of pharmaceutical products and dietary supplements seized from the black market among bodybuilders","volume":"322","author":"Fabresse","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2021.114433_bib18","article-title":"A counterfeit multivitamin product inducing severe bleeding disorders in humans","author":"Pena-Acevedo","year":"2020","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.jpba.2021.114433_bib19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/foods9081012","article-title":"Dietary supplement and food contaminations and their implications for doping controls","volume":"9","author":"Walpurgis","year":"2020","journal-title":"Foods"},{"key":"10.1016\/j.jpba.2021.114433_bib20","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3390\/nu9101093","article-title":"Intended or unintended doping? A review of the presence of doping substances in dietary supplements used in sports","volume":"9","author":"Martinez-Sanz","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.jpba.2021.114433_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/dta.91","article-title":"Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black market product","volume":"1","author":"Thevis","year":"2009","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2021.114433_bib22","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/dta.2933","article-title":"Elimination profiles of microdosed ostarine mimicking contaminated products ingestion","volume":"12","author":"Walpurgis","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2021.114433_bib23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/dta.2908","article-title":"Analysis of supplements available to UK consumers purporting to contain selective androgen receptor modulators","volume":"13","author":"Leaney","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2021.114433_bib24","first-page":"56","article-title":"LGD-4033, S-4 and MK-2866 \u2013 testing for SARMs in hair: about 2 doping cases","volume":"31","author":"Kintz","year":"2019","journal-title":"Toxicol. Anal. Clin."},{"key":"10.1016\/j.jpba.2021.114433_bib25","unstructured":"\u27e8https:\/\/www.usada.org\/athlete-advisory\/growing-evidence-ostarine-athlete-risk\/\u27e9, accessed 28 June 2021."},{"key":"10.1016\/j.jpba.2021.114433_bib26","unstructured":"\u27e8https:\/\/www.usada.org\/athletes\/substances\/supplement-411\/\u27e9, accessed 28 June 2021."},{"key":"10.1016\/j.jpba.2021.114433_bib27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/19440049.2021.1906954","article-title":"Development and validation of liquid chromatography-tandem mass spectrometry method for screening six selective androgen receptor modulators in dietary supplements","volume":"38","author":"Lee","year":"2021","journal-title":"Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess."},{"key":"10.1016\/j.jpba.2021.114433_bib28","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/19440049.2020.1757165","article-title":"Investigation of stability of selective androgen receptor modulators in urine","volume":"37","author":"Ventura","year":"2020","journal-title":"Food Addit. Contam. Part A Anal. Control Expo. Risk Assess."},{"key":"10.1016\/j.jpba.2021.114433_bib29","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/dta.2512","article-title":"Human in vivo metabolism study of LGD-4033","volume":"10","author":"Fragkaki","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2021.114433_bib30","article-title":"Enhanced UHPLC-MS\/MS screening of selective androgen receptor modulators following urine hydrolysis","volume":"7","author":"Gagaj","year":"2020","journal-title":"MethodsX"},{"key":"10.1016\/j.jpba.2021.114433_bib31","unstructured":"\u27e8https:\/\/www.theguardian.com\/sport\/2013\/dec\/31\/wada-craig-reedie-drug-cheats-doping-hair\u27e9, accessed 28 June 2021."},{"key":"10.1016\/j.jpba.2021.114433_bib32","first-page":"5480","article-title":"Hair analysis in forensic toxicology: an update review with a special focus on pitfalls","volume":"23","author":"Kintz","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpba.2021.114433_bib33","first-page":"3","article-title":"Consensus of the society of hair testing on hair testing for doping agents","volume":"107","author":"Sachs","year":"2000","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2021.114433_bib34","unstructured":"\u27e8https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2021_wada_code.pdf\u27e9, accessed 28 June 2021."},{"key":"10.1016\/j.jpba.2021.114433_bib35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/dta.2766","article-title":"Hair testing for doping agents. What is known and what remains to do","volume":"12","author":"Kintz","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2021.114433_bib36","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/dta.2902","article-title":"Identification of S-22 (ostarine) in human nails and hair using LC-HRMS. Application to two authentic cases","volume":"12","author":"Kintz","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2021.114433_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/FTD.0000000000000859","article-title":"Perspectives in evaluating selective androgen receptors modulators in human hair: a short communication","volume":"43","author":"Kintz","year":"2021","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2021.114433_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/dta.2943","article-title":"Detection of the selective androgen receptor modulator GSK2881078 and metabolites in urine and hair after single oral administration","volume":"13","author":"Rading","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2021.114433_bib39","unstructured":"\u27e8https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/isl_2021.pdf\u27e9, accessed 28 June 2021."},{"key":"10.1016\/j.jpba.2021.114433_bib40","unstructured":"\u27e8https:\/\/plus.lapresse.ca\/screens\/f59b2204-beca-475a-97e9\u20135a445b2ab51a__7C___0.html\u27e9, accessed 28 June 2021."},{"key":"10.1016\/j.jpba.2021.114433_bib41","unstructured":"\u27e8https:\/\/www.canoeicf.com\/news\/icf-decision-laurence-vincent-lapointe\u27e9, accessed 28 June 2021."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521005446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521005446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:19:48Z","timestamp":1760001588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708521005446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":41,"alternative-id":["S0731708521005446"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114433","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114433"}}